Content
Marketing Brochure
View the marketing brochure (pdf) includes a full table of contents
Executive Summary
View the Executive Summary (pdf)
1: Introduction and Scope of Report
2: Novel Formulations of Top-Selling Non-Biological (Small-Molecule) Drugs
3: Peptides
- Rationale for Developing Peptides as Drugs
- Peptides in Clinical Trials
- Peptides in Pre-clinical Research and Development
4: Polypeptides and Proteins
- Human Growth Hormone (hGH)
- Insulin
- Inhaled Insulin
- Other Formulations of Insulin
- Proteins
- Erythropoietin
- Factor VIII
- G-CSF (Growth Colony Stimulating Factor)
- Interferon Alfa
- Interferon Beta
- Interleukin-2 (IL-2)
- Miscellaneous Proteins
- Miscellaneous Proteins and Polypeptides in Research and Development
- Companies Specialising in Delivery of Peptides and Proteins
5: Oligonucleotides
6: Pulmonary (Inhaled) Delivery
- Products in Research and Development Based on Pulmonary Delivery
- Companies Specialising in the Development of Novel Pulmonary Devices and Formulations
7: Nasal Delivery
- Products in Research and Development and Based on Nasal Delivery
- Companies with Expertise in Nasal Delivery
8: Buccal Delivery
9: Transdermal Delivery
- Transdermal Estradiol Formulations in Research and Development
- Transdermal Testosterone Formulations in R&D
- Companies Developing Novel Transdermal Formulation SystemsEvaluating the target company
10: Pegylation
- Companies with Expertise in PEGylation
11: Liposomes and Lipid Formulations
12: Oral Delivery of Drugs
13: Parenteral Delivery of Drugs
14: Company Profiles
- Acrux
- Adprotech
- Advancis Pharmaceutical
- Aerogen
- Alkermes
- Alza
- Andrx Pharmaceuticals
- Antares Pharma
- AP Pharma
- Applied Pharma Research
- Aradigm
- Atrix Laboratories
- Aventis Respiratory Technology
- BattellePharma
- Bentley Pharmaceuticals
- Bespak
- Biovail
- Boehringer Ingelheim
- Cardinal Health
- Chienna
- Chiesi
- CIMA Laboratories
- Columbia Laboratories
- DepoMed
- Diatos
- Direct-Haler
- DOR BioPharma
- Durect
- Elan
- Emisphere Technologies
- Enzon Pharmaceuticals
- Epic Therapeutics
- Epicept
- Ethypharm
- Eurand
- FeRx
- Flamel Technologies
- Focus Inhalation
- Generex Biotechnology
- Hovione
- Inex Pharmaceuticals
- IVAX
- Kosmos Pharma
- Labopharm Macrochem
- Meridica
- ML Laboratories
- Mundipharma
- NanoCarrier
- Nastech Pharmaceutical
- Nektar Therapeutics
- Neopharm
- Nobex
- NovaDel Pharmaceuticals
- Novavax
- Noven Pharmaceuticals
- Octoplus
- Omeros Medical Systems
- Osmopharm
- PARI
- Penwest Pharmaceuticals
- Polygene
- Profile Respiratory Systems
- PR Pharmaceuticals
- Protarga
- QuatRx
- Regulon
- Salus Therapeutics
- Sheffield Pharmaceuticals
- Skye Pharma
- Spherics
- Theratechnologies
- Transave
- Transdermal Technologies
- Unigene Laboratories
- Valentis
- Watson Pharmaceuticals
- West Pharmaceuticals
- ZentRx
Appendix: Forumulations of Leading 150 Products
List of Tables
- Table 2.1 Novel Formulations of Selected Pharmaceuticals in Development
- Table 3.1 Peptides on the Market as Therapeutic Agents
- Table 3.2 Peptides in Clinical Trials
- Table 3.3 Indications of Peptides in Clinical Trials
- Table 3.4 Peptides in Pre-clinical Research and Development
- Table 4.1 Sales of Growth Hormone in 2001
- Table 4.2 Novel Formulations of Human Growth Hormone in Research and Development
- Table 4.3 Insulin Sales by Major Companies in 2001
- Table 4.4 Novel Formulations of Insulin in Research and Development
- Table 4.5 Selected Proteins, Including 2001 Sales
- Table 4.6 New Formulations of Erythropoietin in Research and Development
- Table 4.7 Formulations of G(M)CSF in Research and Development
- Table 4.8 Formulations of Interferon Alfa in Clinical and Pre-clinical Trials
- Table 4.9 Novel Formulations of Interferon Beta in Research and Development
- Table 4.10 Miscellaneous Proteins and Polypeptides in Clinical and Pre-clinical Trials
- Table 4.11 Companies Specialising in Peptide and Protein Delivery
- Table 5.1 Oligonucleotides in Research and Development
- Table 5.2 Companies with Technologies for Delivery of Oligonucleotides
- Table 6.1 Major Products on the Market Using Pulmonary-delivery Devices
- Table 6.2 Products in Research and Development Using Pulmonary Delivery
- Table 6.3 Companies Specialising in the Development of Novel Inhalation Devices and Formulation Technology
- Table 7.1 Commercial Products Using Nasal-delivery Devices
- Table 7.2 New Products in Development Using Nasal-delivery Devices
- Table 7.3 Companies with Expertise in Nasal Delivery
- Table 8.1 Companies with Specialist Technology for Buccal-delivery Systems
- Table 9.1 Novel Products in Research and Development Employing Transdermal- delivery Systems
- Table 9.2 Selected Companies Specialising in Transdermal Delivery
- Table 10.1 PEGylated Products in Research and Development
- Table 10.2 Companies with Expertise in PEGylation
- Table 11.1 Companies Developing Liposomal and Lipid-based Formulations
- Table 12.1 Companies Specialising in Oral Formulation Technology
- Table 13.1 Companies Specialising in Parenteral Formulation Technology
| 
View Cart
